Skip to search formSkip to main contentSkip to account menu

PROSURE

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
[A Nutritional Supplement with a High Blend Ratio of ω-3 Fatty Acids(Prosure®) Reduces Severe Oral Mucositis and Body Weight Loss for Head and Neck Cancer Patients Treated with Chemoradiotherapy].
BACKGROUND Oral mucositis and body weight loss are the most critical conditions known to lead to the discontinuation of… 
2018
2018
Prospective randomized investigation implementing immunonutritional therapy using a nutritional supplement with a high blend ratio of &ohgr;-3 fatty acids during the perioperative period for head and…
Objectives The purpose of this study is to evaluate whether a nutritional supplement with a high blend ratio of ω-3 fatty acids… 
Highly Cited
2017
Highly Cited
2017
Randomized clinical trial comparing standard diet with perioperative oral immunonutrition in total gastrectomy for gastric cancer
Total gastrectomy for gastric cancer is associated with excessive weight loss and decreased calorie intake. Nutritional support… 
Highly Cited
2017
Highly Cited
2017
A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer
Cancer cachexia is a syndrome of weight loss (including muscle and fat), anorexia, and decreased physical function. It has been… 
2013
2013
[Effect of enteral nutrition enriched with eicosapentaenoic acid on body weight loss and compliance with S-1 adjuvant chemotherapy after gastric cancer surgery].
BACKGROUND Eicosapentaenoic acid-enriched oral nutritional supplements (Prosure®; Abbott Japan, Tokyo, Japan) may attenuate… 
2011
2011
Randomized phase II study of gemcitabine monotherapy versus gemcitabine with an EPA-enriched oral supplement in advanced pancreatic cancer (YCOG001).
e15109 Background: Gemcitabine is one of the standard chemotherapeutic agents for pancreatic cancer. Pancreatic cancer is often… 
2011
2011
Randomized phase II study of gemcitabine monotherapy versus gemcitabine with an EPA-enriched oral supplement in advanced pancreatic cancer (YCOG001).
e14552 Background: Gemcitabine is still standard chemotherapy in pancreatic cancer. Pancreatic cancer patients often have… 
2011
2011
Omega 3 fatty acids supplementation has an ameliorative effect in experimental ulcerative colitis despite increased colonic neutrophil infiltration.
PURPOSE omega 3 polyunsaturated fatty acids have anti-inflammatory properties and can be beneficial in the treatment of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)